← Back to headlines
Biogen and Nabors Outline Future Financial Projections
Biogen has outlined its non-GAAP EPS expectations for 2026 and growth targets for key products, while Nabors has provided its full-year EBITDA and free cash flow targets for 2026.
29 Jul, 22:24 — 29 Jul, 22:24
Sources
Showing 1 of 1 sources
